Abstract:The identification of anticancer peptides (ACPs) is crucial, especially in the development of peptide-based cancer therapy. The classical models such as Split Amino Acid Composition (SAAC) and Pseudo Amino Acid Composition (PseAAC) lack the incorporation of feature representation. These advancements improve the predictive accuracy and efficiency of ACP identification. Thus, the effort of this research is to propose and develop an advanced framework based on feature extraction. Thus, to achieve this objective herein we propose an Extended Dipeptide Composition (EDPC) framework. The proposed EDPC framework extends the dipeptide composition by considering the local sequence environment information and reforming the CD-HIT framework to remove noise and redundancy. To measure the accuracy, we have performed several experiments. These experiments were employed using four famous machine learning (ML) algorithms named; Support Vector Machine (SVM), Decision Tree (DT), Random Forest (RF), and K Nearest Neighbor (KNN). For comparisons, we have used accuracy, specificity, sensitivity, precision, recall, and F1-Score as evaluation criteria. The reliability of the proposed framework is further evaluated using statistical significance tests. As a result, the proposed EDPC framework exhibited enhanced performance than SAAC and PseAAC, where the SVM model delivered the highest accuracy of 96. 6% and significant enhancements in specificity, sensitivity, precision, and F1-score over multiple datasets. Due to the incorporation of enhanced feature representation and the incorporation of local and global sequence profiles proposed EDPC achieves higher classification performance. The proposed frameworks can deal with noise and also duplicating features. These are accompanied by a wide range of feature representations. Finally, our proposed framework can be used for clinical applications where ACP identification is essential. Future works will include extending to a larger variety of datasets, incorporating tertiary structural information, and using deep learning techniques to improve the proposed EDPC.

Anti-Cancer Peptides Identification and Activity Type Classification with Protein Sequence Pre-training

ACP-ML: A sequence-based method for anticancer peptide prediction

Effective identification and differential analysis of anticancer peptides

ACPScanner: Prediction of Anticancer Peptides by Integrated Machine Learning Methodologies

Prediction of anticancer peptides based on an ensemble model of deep learning and machine learning using ordinal positional encoding

To Assist Oncologists: An Efficient Machine Learning-Based Approach for Anti-Cancer Peptides Classification

Large-scale comparative review and assessment of computational methods for anti-cancer peptide identification

ACPNet: A Deep Learning Network to Identify Anticancer Peptides by Hybrid Sequence Information

ACP-MLC: A two-level prediction engine for identification of anticancer peptides and multi-label classification of their functional types

ANNprob-ACPs: A novel anticancer peptide identifier based on probabilistic feature fusion approach

iACP-DFSRA: Identification of Anticancer Peptides Based on a Dual-channel Fusion Strategy of ResCNN and Attention

ACP-check: An anticancer peptide prediction model based on bidirectional long short-term memory and multi-features fusion strategy

ACP-CapsPred: an explainable computational framework for identification and functional prediction of anticancer peptides based on capsule network

Peptide-Based Drug Predictions for Cancer Therapy Using Deep Learning

ACP-DA: Improving the Prediction of Anticancer Peptides Using Data Augmentation

Anticancer Peptides Classification using Kernel Sparse Representation Classifier

ACP-ESM2: The Prediction of Anticancer Peptides Based on Pre-trained Classifier

ACP-DRL: an anticancer peptides recognition method based on deep representation learning

Extended dipeptide composition framework for accurate identification of anticancer peptides

MA‐PEP: A novel anticancer peptide prediction framework with multimodal feature fusion based on attention mechanism

Contrastive learning for enhancing feature extraction in anticancer peptides